Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Biosimilars market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Mylan
Teva Pharmaceutical
Roche Diagnostics
Sandoz International
Hospira
Amgen
Celltrion
Biocon
Merck KGaA
By Type:
Injection
Tablets
Others
By End-User:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars Market
-
1.3 Market Segment by Type
-
1.3.1 Japan Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026
-
1.3.2 Japan Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026
-
1.3.3 Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
-
1.4.1 Market Size and Growth Rate of Ankylosing Spondylitis
-
1.4.2 Market Size and Growth Rate of Tumor
-
1.4.3 Market Size and Growth Rate of Rheumatoid Arthrtis
-
1.4.4 Market Size and Growth Rate of Cardiovascular
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilars by Major Types
-
3.4.1 Japan Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026
-
3.4.2 Japan Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026
-
3.4.3 Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
4 Segmentation of Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilars by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilars in Ankylosing Spondylitis
-
4.4.2 Market Size and Growth Rate of Biosimilars in Tumor
-
4.4.3 Market Size and Growth Rate of Biosimilars in Rheumatoid Arthrtis
-
4.4.4 Market Size and Growth Rate of Biosimilars in Cardiovascular
5 Market Analysis by Regions
-
5.1 Japan Biosimilars Production Analysis by Regions
-
5.2 Japan Biosimilars Consumption Analysis by Regions
6 Hokkaido Biosimilars Landscape Analysis
-
6.1 Hokkaido Biosimilars Landscape Analysis by Major Types
-
6.2 Hokkaido Biosimilars Landscape Analysis by Major End-Users
7 Tohoku Biosimilars Landscape Analysis
-
7.1 Tohoku Biosimilars Landscape Analysis by Major Types
-
7.2 Tohoku Biosimilars Landscape Analysis by Major End-Users
8 Kanto Biosimilars Landscape Analysis
-
8.1 Kanto Biosimilars Landscape Analysis by Major Types
-
8.2 Kanto Biosimilars Landscape Analysis by Major End-Users
9 Chubu Biosimilars Landscape Analysis
-
9.1 Chubu Biosimilars Landscape Analysis by Major Types
-
9.2 Chubu Biosimilars Landscape Analysis by Major End-Users
10 Kinki Biosimilars Landscape Analysis
-
10.1 Kinki Biosimilars Landscape Analysis by Major Types
-
10.2 Kinki Biosimilars Landscape Analysis by Major End-Users
11 Chugoku Biosimilars Landscape Analysis
-
11.1 Chugoku Biosimilars Landscape Analysis by Major Types
-
11.2 Chugoku Biosimilars Landscape Analysis by Major End-Users
12 Shikoku Biosimilars Landscape Analysis
-
12.1 Shikoku Biosimilars Landscape Analysis by Major Types
-
12.2 Shikoku Biosimilars Landscape Analysis by Major End-Users
13 Kyushu Biosimilars Landscape Analysis
-
13.1 Kyushu Biosimilars Landscape Analysis by Major Types
-
13.2 Kyushu Biosimilars Landscape Analysis by Major End-Users
14 Major Players Profiles
-
14.1 Mylan
-
14.1.1 Mylan Company Profile and Recent Development
-
14.1.2 Mylan Market Performance
-
14.1.3 Mylan Product and Service Introduction
-
14.2 Teva Pharmaceutical
-
14.2.1 Teva Pharmaceutical Company Profile and Recent Development
-
14.2.2 Teva Pharmaceutical Market Performance
-
14.2.3 Teva Pharmaceutical Product and Service Introduction
-
14.3 Roche Diagnostics
-
14.3.1 Roche Diagnostics Company Profile and Recent Development
-
14.3.2 Roche Diagnostics Market Performance
-
14.3.3 Roche Diagnostics Product and Service Introduction
-
14.4 Sandoz International
-
14.4.1 Sandoz International Company Profile and Recent Development
-
14.4.2 Sandoz International Market Performance
-
14.4.3 Sandoz International Product and Service Introduction
-
14.5 Hospira
-
14.5.1 Hospira Company Profile and Recent Development
-
14.5.2 Hospira Market Performance
-
14.5.3 Hospira Product and Service Introduction
-
14.6 Amgen
-
14.6.1 Amgen Company Profile and Recent Development
-
14.6.2 Amgen Market Performance
-
14.6.3 Amgen Product and Service Introduction
-
14.7 Celltrion
-
14.7.1 Celltrion Company Profile and Recent Development
-
14.7.2 Celltrion Market Performance
-
14.7.3 Celltrion Product and Service Introduction
-
14.8 Biocon
-
14.8.1 Biocon Company Profile and Recent Development
-
14.8.2 Biocon Market Performance
-
14.8.3 Biocon Product and Service Introduction
-
14.9 Merck KGaA
-
14.9.1 Merck KGaA Company Profile and Recent Development
-
14.9.2 Merck KGaA Market Performance
-
14.9.3 Merck KGaA Product and Service Introduction
The List of Tables and Figures (Totals 85 Figures and 181 Tables)
-
Figure Japan Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026
-
Figure Japan Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026
-
Figure Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
-
Figure Market Size and Growth Rate of Ankylosing Spondylitis
-
Figure Market Size and Growth Rate of Tumor
-
Figure Market Size and Growth Rate of Rheumatoid Arthrtis
-
Figure Market Size and Growth Rate of Cardiovascular
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Biosimilars Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Biosimilars
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilars by Different Types from 2014 to 2026
-
Table Consumption Share of Biosimilars by Different Types from 2014 to 2026
-
Figure Japan Biosimilars Market Size and Growth Rate of Injection from 2014 to 2026
-
Figure Japan Biosimilars Market Size and Growth Rate of Tablets from 2014 to 2026
-
Figure Japan Biosimilars Market Size and Growth Rate of Others from 2014 to 2026
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Biosimilars by Different End-Users from 2014 to 2026
-
Table Consumption Share of Biosimilars by Different End-Users from 2014 to 2026
-
Figure Market Size and Growth Rate of Ankylosing Spondylitis
-
Figure Market Size and Growth Rate of Tumor
-
Figure Market Size and Growth Rate of Rheumatoid Arthrtis
-
Figure Market Size and Growth Rate of Cardiovascular
-
Table Japan Biosimilars Production by Regions
-
Table Japan Biosimilars Production Share by Regions
-
Figure Japan Biosimilars Production Share by Regions in 2014
-
Figure Japan Biosimilars Production Share by Regions in 2018
-
Figure Japan Biosimilars Production Share by Regions in 2026
-
Table Japan Biosimilars Consumption by Regions
-
Table Japan Biosimilars Consumption Share by Regions
-
Figure Japan Biosimilars Consumption Share by Regions in 2014
-
Figure Japan Biosimilars Consumption Share by Regions in 2018
-
Figure Japan Biosimilars Consumption Share by Regions in 2026
-
Table Hokkaido Biosimilars Consumption by Types from 2014 to 2026
-
Table Hokkaido Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Biosimilars Consumption Share by Types in 2014
-
Figure Hokkaido Biosimilars Consumption Share by Types in 2018
-
Figure Hokkaido Biosimilars Consumption Share by Types in 2026
-
Table Hokkaido Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Biosimilars Consumption Share by End-Users in 2014
-
Figure Hokkaido Biosimilars Consumption Share by End-Users in 2018
-
Figure Hokkaido Biosimilars Consumption Share by End-Users in 2026
-
Table Tohoku Biosimilars Consumption by Types from 2014 to 2026
-
Table Tohoku Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Biosimilars Consumption Share by Types in 2014
-
Figure Tohoku Biosimilars Consumption Share by Types in 2018
-
Figure Tohoku Biosimilars Consumption Share by Types in 2026
-
Table Tohoku Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Tohoku Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Biosimilars Consumption Share by End-Users in 2014
-
Figure Tohoku Biosimilars Consumption Share by End-Users in 2018
-
Figure Tohoku Biosimilars Consumption Share by End-Users in 2026
-
Table Kanto Biosimilars Consumption by Types from 2014 to 2026
-
Table Kanto Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kanto Biosimilars Consumption Share by Types in 2014
-
Figure Kanto Biosimilars Consumption Share by Types in 2018
-
Figure Kanto Biosimilars Consumption Share by Types in 2026
-
Table Kanto Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kanto Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Biosimilars Consumption Share by End-Users in 2014
-
Figure Kanto Biosimilars Consumption Share by End-Users in 2018
-
Figure Kanto Biosimilars Consumption Share by End-Users in 2026
-
Table Chubu Biosimilars Consumption by Types from 2014 to 2026
-
Table Chubu Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chubu Biosimilars Consumption Share by Types in 2014
-
Figure Chubu Biosimilars Consumption Share by Types in 2018
-
Figure Chubu Biosimilars Consumption Share by Types in 2026
-
Table Chubu Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chubu Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Biosimilars Consumption Share by End-Users in 2014
-
Figure Chubu Biosimilars Consumption Share by End-Users in 2018
-
Figure Chubu Biosimilars Consumption Share by End-Users in 2026
-
Table Kinki Biosimilars Consumption by Types from 2014 to 2026
-
Table Kinki Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kinki Biosimilars Consumption Share by Types in 2014
-
Figure Kinki Biosimilars Consumption Share by Types in 2018
-
Figure Kinki Biosimilars Consumption Share by Types in 2026
-
Table Kinki Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kinki Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Biosimilars Consumption Share by End-Users in 2014
-
Figure Kinki Biosimilars Consumption Share by End-Users in 2018
-
Figure Kinki Biosimilars Consumption Share by End-Users in 2026
-
Table Chugoku Biosimilars Consumption by Types from 2014 to 2026
-
Table Chugoku Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Biosimilars Consumption Share by Types in 2014
-
Figure Chugoku Biosimilars Consumption Share by Types in 2018
-
Figure Chugoku Biosimilars Consumption Share by Types in 2026
-
Table Chugoku Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Chugoku Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Biosimilars Consumption Share by End-Users in 2014
-
Figure Chugoku Biosimilars Consumption Share by End-Users in 2018
-
Figure Chugoku Biosimilars Consumption Share by End-Users in 2026
-
Table Shikoku Biosimilars Consumption by Types from 2014 to 2026
-
Table Shikoku Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Biosimilars Consumption Share by Types in 2014
-
Figure Shikoku Biosimilars Consumption Share by Types in 2018
-
Figure Shikoku Biosimilars Consumption Share by Types in 2026
-
Table Shikoku Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Shikoku Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Biosimilars Consumption Share by End-Users in 2014
-
Figure Shikoku Biosimilars Consumption Share by End-Users in 2018
-
Figure Shikoku Biosimilars Consumption Share by End-Users in 2026
-
Table Kyushu Biosimilars Consumption by Types from 2014 to 2026
-
Table Kyushu Biosimilars Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Biosimilars Consumption Share by Types in 2014
-
Figure Kyushu Biosimilars Consumption Share by Types in 2018
-
Figure Kyushu Biosimilars Consumption Share by Types in 2026
-
Table Kyushu Biosimilars Consumption by End-Users from 2014 to 2026
-
Table Kyushu Biosimilars Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Biosimilars Consumption Share by End-Users in 2014
-
Figure Kyushu Biosimilars Consumption Share by End-Users in 2018
-
Figure Kyushu Biosimilars Consumption Share by End-Users in 2026
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
Table Company Profile and Development Status of Roche Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics
-
Figure Sales and Growth Rate Analysis of Roche Diagnostics
-
Figure Revenue and Market Share Analysis of Roche Diagnostics
-
Table Product and Service Introduction of Roche Diagnostics
-
Table Company Profile and Development Status of Sandoz International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International
-
Figure Sales and Growth Rate Analysis of Sandoz International
-
Figure Revenue and Market Share Analysis of Sandoz International
-
Table Product and Service Introduction of Sandoz International
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Merck KGaA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA
-
Figure Sales and Growth Rate Analysis of Merck KGaA
-
Figure Revenue and Market Share Analysis of Merck KGaA
-
Table Product and Service Introduction of Merck KGaA
-
